Delivery Order SPE2DB24D2101-SPE2DB25FKNTH
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 28, 2025, for Welireg 40 mg tablets (90-count packages) with a ceiling value of $17,968.39. This firm fixed-price, non-set-aside contract is scheduled for completion by August 18, 2025, and represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Welireg 40 mg tablets (90-count units) valued at $17,968.39. This firm fixed-price delivery order is scheduled for completion by September 23, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability to meet federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Welireg 40 mg tablets (90-count) with a ceiling value of $17,968.39. This firm fixed-price delivery order, with an ultimate completion date of October 1, 2025, represents a non-competitive, competitively awarded contract and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 90-count tablets of Welireg 40 mg, with a contract value of $17,968.39. The award, issued on August 21, 2025, represents a firm fixed-price delivery order with an ultimate completion date of September 12, 2025. This contract carries no set-aside designation and was competitively awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Welireg 40 mg tablets (90-count units) with a ceiling value of $17,968.39. This firm fixed-price delivery order, with an ultimate completion date of October 17, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp will perform the work at its corporate office location in Conshohocken, Pennsylvania. The contract is issued as a...
- The Defense Logistics Agency awarded a delivery order valued at $71,873.56 to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Welireg 40 mg tablets (90-count units). This firm fixed-price, non-set-aside contract is scheduled for completion by October 6, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is well-positioned to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,968.39 firm fixed-price delivery order is for the supply of Welireg 40 mg tablets. The contract has an ultimate completion date of May 13, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $17,368.14 contract is for the provision of WELIREG 40 MG TABLET 90S, a prescription pharmaceutical product, with a completion date of February 27, 2024. Amerisourcebergen Drug Corp, as the prime contractor, is a global pharmaceutical sourcing and distribution services company that has received numerous...
- The Defense Logistics Agency awarded a $35,936.78 delivery order to AmerisourceBergen Drug Corp for 90-tablet supplies of Welireg 40 mg, a pharmaceutical product, with performance in Conshohocken, Pennsylvania and completion targeted for September 8, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child order under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. This delivery order executes...
- This federal contract award, valued at $17,968.39, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of WELIREG 40 MG TABLET 90S, a pharmaceutical product, with a completion date of January 24, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. It is not associated with any set-aside designation, indicating open competition....
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKNTHDelivery Order
AmerisourceBergen Drug Corp was awarded a $17,968.39 delivery order by the Defense Logistics Agency on August 21, 2025, for the supply of Welireg 40 mg tablets (90-count units). This is a firm fixed price contract with no set-aside designation, competitively awarded under an open solicitation process. The contract specifies a place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of September 12, 2025. This delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for the Defense Logistics Agency's Medical Supply Chain, providing a comprehensive range of medications, vaccines, and medical supplies to support military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive experience fulfilling pharmaceutical procurement requirements across multiple therapeutic domains, with delivery orders consistently utilizing firm fixed pricing structures. This particular award represents one of many pharmaceutical deliveries under the company's prime vendor agreement with DLA, which enables the supply of specialized medications and medical commodities to support Defense Health Agency operations and other federal healthcare systems globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.0k | 8/21/25 |